Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“ICS patients treated with FP had a mean increase of 0.08 +/- 0.02 L compared with a decrease in forced expiratory volume in 1 second of -0.08 +/- 0.03 L with placebo (P < 0.001).”
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology • 2002 | View Paper
“… si … e rsus 0.03 L, P < .001), morning PEF (17.8 versus 3.1 L/min, P = .004), evening PEF (16.7 versus 2.6 L/min, … of 0.27 puffs/day, P < .001) and combined symptom scores (-0.13 versus an increase of 0.08, P < .001) compared with zafirlukast.”
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology • 2000 | View Paper
“At endpoint, both FP , 220 microg bid, and FP, 88 microg, plus SL, 42 microg bid, significantly increased FEV1 by 0.48 L and 0.58 L, respectively, compared with 0.34 L with TAA, 600 microg bid.”
“… FF 100 μg resulted in an increased 24-hour weighted mean FEV1; … AM and PM FF dosing versus placebo were 0.077 L (90% confidence interval [CI]: 0.001, 0.152) and 0.105 L (90% …), respectively (adjusted mean difference: -0.028 L [90% CI: -0.102, 0.045]).”